IC Potash announces pending move of trading venue to Canadian Securities Exchange

TORONTO, Nov. 07, 2017 - IC Potash Corp. (TSX:ICP) (OTCQB:ICPTF) (“IC Potash” or the “Company”) is pleased to announce that the Board of Directors of the Company has determined it is in the best interests of shareholders to transfer the Company’s listing to The Canadian Securities Exchange (the “CSE”). The CSE is operated by CNSX Markets Inc. The CSE began operations in 2003 to provide a modern and efficient trading and listing platform for companies accessing Canadian public capital markets. Multiple companies in the medical cannabis space are listed on the Canadian Stock Exchange.

The Company is working with the Canadian regulators to voluntarily delist its issued and outstanding common shares from the Toronto Stock Exchange (the “TSX”) in order that the transfer to the CSE can be completed. The Company has now received conditional approval to list its common shares on the CSE and intends to make a seamless transition to the CSE on or about November 22, 2017.

Mr. Mehdi Azodi, President and CEO stated, “Due to the expansion of operation in the legal medical cannabis sector, the CSE listing becomes an extremely attractive market for the trading securities of IC Potash.”


About IC Potash

IC Potash is establishing a diversified portfolio of investments and interests with initial focus on organic fertilizers and resource assets. ICP Organics’, a wholly owned subsidiary of IC Potash Corp., focal point is research, development and investment in the fertilizer and medical cannabis sectors, with emphasis on organic fertilizers, pesticide-free products, and specialty cannabis-related consumer product branding and retail sales. Organic products provide value-enhancing opportunities to medical cannabis and other agricultural growers allowing the producers to sell products at premium prices. The introduction of blockchain technology to the cannabis industry will form the foundation for secure operational processes and streamline domestic and international distribution networks.

IC Potash intends to establish joint research and development partnerships with Canadian Licensed Producers operating under ACMPR regulations in Canada. The Company is also establishing commercial relationships with medical and recreational cannabis producers in the United States. IC Potash has made an equity investment in cannabis operations in South America. As IC Potash grows, it plans to build a diversified portfolio in commercial-scale cannabis cultivators and related downstream cannabis industry providers. The Company may invest in various private and public companies in diversified sectors on an opportunistic basis.

For more information, please visit www.icpotash.com.


Forward-Looking Statements

Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties and other factors which may cause the actual results, performance or achievements of IC Potash to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Forward-looking statements include statements that use forward-looking terminology such as “may”, “will”, “expect”, “anticipate”, “believe”, “continue”, “potential” or the negative thereof or other variations thereof or comparable terminology. Such forward-looking statements include, without limitation, statements regarding planned investment activities & related returns, trends in the markets for fertilizers and medicinal or recreational use of cannabis, the timing or assurance of the legalization of recreational cannabis, the timing for completion of research and development activities, the potential value of royalties from water and other resources, and other statements that are not historical facts. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of IC Potash, including, but not limited to, changes in market trends, the completion, results and timing of research undertaken by IC Potash, risks associated with resource assets, the impact of general economic conditions, commodity prices, industry conditions, dependence upon regulatory, environmental, and governmental approvals, the uncertainty of obtaining additional financing, and risks associated with cannabis use for medicinal or recreational purposes. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements.



For More Information, Please Contact:

Mehdi Azodi, IC Potash, President & CEO
416 779 3268
mazodi@icpotash.org